Ebpay生命医药出版社

Ebpay生命

102494

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

顺利获得沉积在二氧化钛纳米片上的金纳米团簇增强声动力疗法

 

Authors Huang L, Wei L, Li D, Zhang W , Liu L

Received 8 February 2025

Accepted for publication 30 April 2025

Published 14 May 2025 Volume 2025:20 Pages 6121—6131

DOI http://doi.org/10.2147/IJN.S516314

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Sachin Mali

Lei Huang,1,* Lineng Wei,2,* Dan Li,2 Weiqing Zhang,2 Lidong Liu1 

1Department of Medical Imaging Center, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of China; 2Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Weiqing Zhang, Email zhangweiqing@tjut.edu.cn Lidong Liu, Email evanlld@sina.com

Purpose: This study aimed to enhance the efficacy of sonodynamic therapy (SDT) for breast cancer by engineering TiO2 nanosheets modified with Au nanoclusters (TiO2-Au), thereby improving reactive oxygen species (ROS) generation under ultrasound (US) irradiation.
Methods: TiO2-Au sonosensitizers were synthesized via a deposition–precipitation with urea (DPU) method and characterized by TEM, XRD, and XPS. ROS generation efficiency was quantified using DPBF, TMB, and NBT probes, along with electron spin resonance (ESR). In vitro therapeutic performance was assessed in 4T1 breast cancer cells via flow cytometry, Calcein-AM/PI staining, and cell counting kit-8 (CCK-8) assay. In vivo efficacy and biosafety were validated in 4T1 tumor-bearing BALB/c mice through tumor growth monitoring, histological analysis, blood biochemistry, and hemolysis assays.
Results: TiO2-Au10.5 exhibited enhanced electron–hole separation, reduced bandgap (from 3.2 to 2.8 eV), and significantly boosted ROS generation under US irradiation. In vitro, TiO2-Au10.5 combined with US induced a 4.25-fold increase in intracellular ROS and a 4.7-fold higher apoptosis rate compared to TiO2 + US. In vivo, TiO2-Au10.5 + US achieved a tumor growth inhibition index of 76.9% without significant toxicity, as evidenced by normal blood markers, no hemolysis, and no damage to major organs.
Conclusion: Au nanocluster modification effectively tunes the sonodynamic performance of TiO2 nanosheets by modulating electron–hole separation and ROS production. Notably, varying the Au content enabled precise regulation of SDT efficacy, with TiO2-Au10.5 achieving optimal therapeutic outcomes. These findings highlight TiO2-Au as a safe, potent, and composition-tunable sonosensitizer platform for precise and effective cancer therapy.

Keywords: TiO2 nanosheets, gold nanoclusters, Au content modulation, reactive oxygen species, sonodynamic therapy

Download Article[PDF]